Enorama Pharma AB (publ) (STO:ERMA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.770
+0.096 (14.24%)
Mar 9, 2026, 5:11 PM CET
-72.00%
Market Cap 57.43M
Revenue (ttm) 3.63M
Net Income (ttm) -76.57M
Shares Out 74.59M
EPS (ttm) -1.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 25,107
Average Volume 94,739
Open 0.674
Previous Close 0.674
Day's Range 0.672 - 0.800
52-Week Range 0.403 - 3.580
Beta 1.37
RSI 43.85
Earnings Date Feb 17, 2026

About Enorama Pharma AB

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum in Sweden. It offers nicotine chewing gum and nicotine pouches under the NIC-S brand name. The company was incorporated in 2006 and is based in Malmö, Sweden. [Read more]

Sector Healthcare
Founded 2006
Employees 5
Stock Exchange Nasdaq Stockholm
Ticker Symbol ERMA
Full Company Profile

Financial Performance

In 2024, Enorama Pharma AB's revenue was 15.77 million, an increase of 1061.12% compared to the previous year's 1.36 million. Losses were -43.81 million, -1.81% less than in 2023.

Financial Statements

News

There is no news available yet.